Cancer Treatment for Colorectal Cancer Approved
The U.S. Food and Drug Administration (FDA) this week announced that it has approved a new drug for the treatment of colorectal cancer. According to the U.S. Centers for Disease Control and Prevention...
View ArticleCancer Treatment Kevetrin Begins Clinical Trials
Today the Cellceutix Corporation announced that its new anti-cancer drug candidate Kevetrin will soon be entering clinical trials at the Harvard Cancer Center’s Dana-Farber Cancer Institute and Beth...
View ArticleCholesterol Drug Wins FDA Recommendation
Isis Pharmaceuticals recently announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) found the company’s drug, Kynamro (the trade name...
View ArticleMultiple Sclerosis Drug ‘Reboots’ the Immune System
New trials show that a cancer drug can be an effective treatment for multiple sclerosis (MS) by ‘rebooting’ patients’ immune systems. The results of two phase III clinical trials were published today...
View ArticleArthritis Drug Approved by the U.S. FDA
The U.S. Food and Drug Administration this week approved Xeljanz (tofacitinib) for the treatment of moderate to severe rheumatoid arthritis (RA) in adults who have not responded to methotrexate. The...
View ArticleAsthma Drug Rejected by U.K.’s NICE
The U.K.’s National Institute for Health and Clinical Excellence (NICE) this weekend issued a draft guidance stating that it does not recommend omalizumab, an asthma medication marketed as Xolair by...
View ArticleDiabetes Treatment Shown to Improve Memory For Alzheimer’s Patients
A new study shows that a drug used to treat insulin resistance in diabetics could improve cognitive performance in some people with Alzheimer’s disease. In the study, published this week in the Journal...
View ArticleGrapefruit Warning For Medications Expanded
A review published this week in the Canadian Medical Association Journal (CMAJ) warns that while the number of prescription drugs that have adverse effects from interactions with grapefruit are...
View ArticleCholesterol Meds Most Effective With Exercise, Shows Study
A new study shows that cholesterol-lowering drugs have a more significant effect when combined with exercise. Though both the drugs and exercise lower the chances of premature death for people with...
View ArticleMerck Drug Fails Major Clinical Trial
Merck, a major U.S. pharmaceutical company, announced this week that its drug “Tredaptive” has failed a clinical trial. The trial was meant to test the drug for its ability to improve patients’ heart...
View ArticleStroke Medication Approved by the U.S. FDA
A new anti-clotting drug has been approved by the U.S. Food and Drug Administration. Called apixaban and marketed by Bristol-Myers Squibb and Pfizer as Eliquis, the drug has been approved to reduce the...
View ArticleDiabetes Drug Works Differently Than Was Previously Thought
For half a century one of the most popular and most-prescribed classes of diabetes drugs has been biguanides, which includes the drug metformin. Metformin helps to keep liver glucose output in check,...
View ArticleDiabetes Drug Approved by U.S. FDA Committee
A U.S. Food and Drug Administration (FDA) committee this week approved the drug canagliflozin for the treatment of adults with type 2 diabetes. The Endrocrinologic and Metabolic Drugs Advisory...
View ArticleCholesterol Drug Tredaptive Pulled Worldwide
Less than one month ago, Merck, a major U.S. pharmaceutical company, announced that its cholesterol drug Tredaptive failed a major clinical trial. The drug is meant to improve heart health by...
View ArticlePurdue, Maker of OxyContin, Keeps a List of Bad Docs
Earlier this year, the FDA made headlines when it prevented pharmaceutical giant Purdue Pharma from continuing to produce generic and crushable versions of the popular opioid OxyContin. The New York...
View ArticleMerck Job Cuts On the Rise, Cuts Could Prove Beneficial
For months, the struggling New Jersey- based pharmaceutical conglomerate has been struggling, and the numbers they’ve been producing have only made their financial woes more evident. But, yesterday the...
View ArticleJohnson & Johnson to Pay $2.2 Billion Over Risperdal Claims
The U.S. Department of Justice and the U.S. Food and Drug Administration (FDA) today announced that Janssen Pharmaceuticals has plead guilty over the misbranding of the drug Risperdal. Janssen and its...
View ArticleDepression Drug Vyvanse Sent Back To Drawing Board
The pharmaceutical group Shire has decided to stop developing the drug Vyvanse for use to treat depression. The Amphetamine-based Vyvanse is a popular ADHD drug, having made over $1.2 billion dollars...
View ArticleFDA Implements Pilot Program For Fast-Track Drug Importation
The U.S. Food and Drug Administration (FDA) today announced that it has begun its two-year Secure Supply Chain Pilot Program. The program is meant to streamline some drug importation for select...
View ArticleNew Painkiller Zohydro: What Parents And Patients Need To Know
Painkiller junkies who’ve diligently done research are anxiously awaiting the arrival of a pill called Zohydro. Meanwhile, a well-meaning coalition of health professionals is also anticipating – the...
View Article
More Pages to Explore .....